These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29367847)

  • 21. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical morphology variations during the menstrual cycle in individuals with and without premenstrual dysphoric disorder.
    Dubol M; Stiernman L; Sundström-Poromaa I; Bixo M; Comasco E
    J Affect Disord; 2024 Jun; 355():470-477. PubMed ID: 38552916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids.
    Stiernman L; Dubol M; Comasco E; Sundström-Poromaa I; Boraxbekk CJ; Johansson M; Bixo M
    Transl Psychiatry; 2023 Apr; 13(1):124. PubMed ID: 37055419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder.
    Dubol M; Wikström J; Lanzenberger R; Epperson CN; Sundström-Poromaa I; Comasco E
    Sci Rep; 2022 Apr; 12(1):5996. PubMed ID: 35397641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T; Reinhard I; Kuehner C
    Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous inhibition of pain and spinal nociception in women with premenstrual dysphoric disorder.
    Palit S; Bartley EJ; Kuhn BL; Kerr KL; DelVentura JL; Terry EL; Rhudy JL
    J Pain Res; 2016; 9():57-66. PubMed ID: 26929663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder.
    Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
    PLoS One; 2012; 7(12):e51929. PubMed ID: 23284821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential grey matter structure in women with premenstrual dysphoric disorder: evidence from brain morphometry and data-driven classification.
    Dubol M; Stiernman L; Wikström J; Lanzenberger R; Neill Epperson C; Sundström-Poromaa I; Bixo M; Comasco E
    Transl Psychiatry; 2022 Jun; 12(1):250. PubMed ID: 35705554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a functional neuroanatomy of premenstrual dysphoric disorder.
    Protopopescu X; Tuescher O; Pan H; Epstein J; Root J; Chang L; Altemus M; Polanecsky M; McEwen B; Stern E; Silbersweig D
    J Affect Disord; 2008 May; 108(1-2):87-94. PubMed ID: 18031826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition.
    Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I
    J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
    Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
    Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual effects on mood symptoms in treated women with bipolar disorder.
    Sit D; Seltman H; Wisner KL
    Bipolar Disord; 2011 May; 13(3):310-7. PubMed ID: 21676134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrually related symptom changes in women with treatment-responsive bipolar disorder.
    Karadag F; Akdeniz F; Erten E; Pirildar S; Yucel B; Polat A; Atmaca M
    Bipolar Disord; 2004 Jun; 6(3):253-9. PubMed ID: 15117404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.